MedTrace Logo

Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels

NCT00803699 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 262

Last updated 2018-05-29

No results posted yet for this study

Summary

In this study, we will evaluate the effectiveness of several doses of oral selenomethionine in raising biomarkers of selenium status including plasma selenium concentrations.

Conditions

  • Nutritional Requirements

Interventions

DIETARY_SUPPLEMENT

placebo

daily placebo capsules for 12 months

DIETARY_SUPPLEMENT

selenium as L-selenomethionine

daily capsules of 50, 100, or 200 micrograms of L-selenomethionine for 12 months

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • USDA Grand Forks Human Nutrition Research Center

    lead FED

Principal Investigators

  • Gerald F Combs, PhD · USDA Grand Forks Human Nutrition Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00803699 on ClinicalTrials.gov